Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksandra Franovic

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cell Cycle (Georgetown, Tex.)|March 30, 2010
HIF-2alpha: many cancers, one engine?Aleksandra Franovic, Stephen Lee
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Human cancers converge at the HIF-2alpha oncogenic axisAleksandra Franovic, Chet E Holterman, Josianne Payette, et al.
Cancer Research|January 14, 2010
ETS-1 oncogenic activity mediated by transforming growth factor alphaChet E Holterman, Aleksandra Franovic, Josianne Payette, et al.
Journal of Thoracic Disease|November 30, 2017
Urine test for <i>EGFR</i> analysis in patients with non-small cell lung cancerAleksandra Franovic, Victoria M Raymond, Mark G Erlander, et al.
Cancer Research|June 17, 2005
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancerKarlene Smith, Lakshman Gunaratnam, Melissa Morley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancerAleksandra Franovic, Lakshman Gunaratnam, Karlene Smith, et al.
Cancer Research|August 17, 2006
Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17Aleksandra Franovic, Isabelle Robert, Karlene Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2014
DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxiaGabriel Lachance, James Uniacke, Timothy E Audas, et al.
Cancer Research|August 23, 2015
Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescenceAleksandra Franovic, Kathryn C Elliott, Laetitia Seguin, et al.
Developmental Cell|August 14, 2014
Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary glandJay S Desgrosellier, Jacqueline Lesperance, Laetitia Seguin, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|March 30, 2010
HIF-2alpha: many cancers, one engine?Aleksandra Franovic, Stephen Lee
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Human cancers converge at the HIF-2alpha oncogenic axisAleksandra Franovic, Chet E Holterman, Josianne Payette, et al.
Cancer Research|January 14, 2010
ETS-1 oncogenic activity mediated by transforming growth factor alphaChet E Holterman, Aleksandra Franovic, Josianne Payette, et al.
Journal of Thoracic Disease|November 30, 2017
Urine test for <i>EGFR</i> analysis in patients with non-small cell lung cancerAleksandra Franovic, Victoria M Raymond, Mark G Erlander, et al.
Cancer Research|June 17, 2005
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancerKarlene Smith, Lakshman Gunaratnam, Melissa Morley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancerAleksandra Franovic, Lakshman Gunaratnam, Karlene Smith, et al.
Cancer Research|August 17, 2006
Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17Aleksandra Franovic, Isabelle Robert, Karlene Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2014
DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxiaGabriel Lachance, James Uniacke, Timothy E Audas, et al.
Cancer Research|August 23, 2015
Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescenceAleksandra Franovic, Kathryn C Elliott, Laetitia Seguin, et al.
Developmental Cell|August 14, 2014
Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary glandJay S Desgrosellier, Jacqueline Lesperance, Laetitia Seguin, et al.
Pageof 3